Tag: WHO

Essential medicines for low-resource settings: further evidence published.

Publications from MSIF and other stakeholders in support of work on access to MS healthcare.

A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS

Addressing barriers to accessing MS healthcare at a global, regional and national level.

Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time

MSIF and neurological organisations' statement during the Essential Medicines List Committee open session

Advocating for the addition of MS treatments to the WHO Essential Medicines List

Efforts to improve access to MS treatments continue

Addressing barriers to accessing treatment at a global, regional and national level

MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders, including MS

MSIF highlights priority actions for MS in the draft global plan